The NSCLC-derived CD166+ cell fraction (CD166+ LCSCs) expressed low levels of Solute Carrier Family 27 Member (SLC27A2), correlating to poor patient survival and poor chemo-response, as well as expressing high levels of Bmi1 and ABCG2. Here, ABCG2 is linked to non-small cell lung carcinoma.